Anne Wojcicki wanted to run things—alone. It was 2009 and her startup 23andMe was riding high, fueled by a steady stream of venture money, intriguing personal accounts of genome exploration, and the ...

Regeneron Pharmaceuticals will acquire 23andMe's assets for $256 million, both companies said. 23andMe filed for Chapter 11 bankruptcy earlier this year. The DNA testing company has faced major ...

Biotech company 23andMe was once hailed as one of the most successful businesses selling DNA analysis services to anybody who could afford one of its saliva test kits. But 18 years after it was ...

The sale of the bankrupt DNA data bank 23andMe is facing delays as the company tries to find a lead bidder that can quickly clear regulatory hurdles and guarantee customer privacy rules will be ...

Andy Page, former president of digital health startups 23andMe and Livongo, joined Caption Health as CEO earlier this year, the San Francisco-based artificial intelligence company announced Oct. 1.

23andMe will keep offering customers its DNA testing services after being bought out of bankruptcy. New York-based biotech company Regeneron Pharmaceuticals announced an agreement on Monday to ...

Maven, a digital health startup providing access to virtual fertility, pregnancy and postpartum services, announced on Feb. 19 the close of a $45 million Series C round that included participation ...